about
Nontuberculous mycobacteria in Middle East: Current situation and future challengesNontuberculous Mycobacteria Isolation from Clinical and Environmental Samples in Iran: Twenty Years of SurveillanceThe recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotypingHIV and tuberculosis trends and survival of coinfection in a referral center in Tehran: A 12-year study.Populations of latent Mycobacterium tuberculosis lack a cell wall: Isolation, visualization, and whole-genome characterizationMycobacterium aurum keratitis: an unusual etiology of a sight-threatening infection.Molecular epidemiology of nontuberculous mycobacteria isolates from clinical and environmental sources of a metropolitan city.Interferon-gamma receptor-1 gene promoter polymorphisms and susceptibility to leprosy in children of a single family.Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.Co-infection of Mycobacterium tuberculosis and Pneumocystis jirovecii in the Iranian Patients With Human Immunodeficiency Virus.Identification and genotyping of Mycobacterium tuberculosis isolated from water and soil samples of a metropolitan city.Utility of Gastric Lavage for Diagnosis of Tuberculosis in Patients who are Unable to Expectorate SputumApplication of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosisTreatment outcome, mortality and their predictors among HIV-associated tuberculosis patients.High prevelance of rifampin-monoresistant tuberculosis: a retrospective analysis among Iranian pulmonary tuberculosis patients.A retrospective analysis of isoniazid-monoresistant tuberculosis: among Iranian pulmonary tuberculosis patients.Association of Mycobacterium Tuberculosis Lineages with IFN-γ and TNF-α Gene Polymorphisms among Pulmonary Tuberculosis Patient.Division-cycle in Mycobacterium tuberculosis.Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.Overview of drug-resistant tuberculosis worldwide.Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide testing by MTBDRsl in Armenia.Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.Association of IFN-γ and P2X7 Receptor Gene Polymorphisms in Susceptibility to Tuberculosis Among Iranian Patients.The NRAMP1, VDR, TNF-α, ICAM1, TLR2 and TLR4 gene polymorphisms in Iranian patients with pulmonary tuberculosis: A case-control study.Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases.Molecular drug susceptibility testing against the first-line (rifampin and isoniazid) and second-line (ciprofloxacin-amikacin and kanamycin) treatment in different subtypes of Mycobacterium simiae.Investigation of urine lipoarabinomannan in human immunodeficiency virus patients with or without coinfection with Tuberculosis in Iran.Deletion of region of difference 181 in Mycobacterium tuberculosis Beijing strains.Molecular detection of fluoroquinolone resistance-associated gyrA mutations in ofloxacin-resistant clinical isolates of Mycobacterium tuberculosis from Iran and Belarus.Impact of diabetes mellitus on tuberculosis drug resistance in new cases of tuberculosis.Nontuberculous Mycobacteria: Epidemiologic, Mycobacteriologic, and Clinical Aspects.Dihydropteroate synthase gene mutation rates in Pneumocystis jirovecii strains obtained from Iranian HIV-positive and non-HIV-positive patients.The NRAMPI, VDR and TNF-alpha gene polymorphisms in Iranian tuberculosis patients: the study on host susceptibility.Extensively drug-resistant tuberculosis treatment outcome in Iran: a case series of seven patients.Totally drug-resistant tuberculosis (TDR-TB): A debate on global health communities.Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients.The most predominant spoligopatterns of Mycobacterium tuberculosis isolates among Iranian, Afghan-immigrant, Pakistani and Turkish tuberculosis patients: a comparative analysis.Latent tuberculosis (TB) bacilli: Yes or no to preventive chemotherapy.Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.Typing of Pneumocystis jirovecii isolates from Iranian immunosuppressed patients based on the Internal Transcribed Spacer (ITS) region of the rRNA gene.
P50
Q26776539-8BD513FD-4807-4808-8C02-F013BFE525ABQ26800290-7F36F29D-1B57-41D5-8E65-3B58131669D7Q33357937-F56512EB-1EF5-46CA-A8DA-985AD3BCDE25Q33438062-9E03CD03-34CF-48CA-A6C3-BFC6EDEA4DF3Q33725460-41B6C976-37F9-4FC2-81CC-8046FEB224F6Q34254136-E5A9487F-4B4B-48AA-B8EE-F715BAEA7960Q34653656-A681D33B-5A3E-4157-A8EF-826FBCC02E52Q34707851-8D44593C-46F8-406C-8B9F-505654988DD5Q34974467-59C05894-4FDB-45B2-A55B-E0606C773307Q35225474-D74EA168-4FB8-4C17-9677-7C93EE644421Q35298577-1BD1D1FD-9996-4AD8-904E-1A0B8D5CEB1FQ35646980-AF9C320F-4A6A-434F-96D9-2AAB52A21ECEQ35716729-BF493881-1FFF-4489-858F-9D477DEC51E6Q36390760-5A81E99D-53E3-4F6C-8EFF-90DFF0440F61Q37456208-9C4C482D-44DF-4184-BC7F-5CB6B8E04DDBQ37618035-DE49B064-3F1B-470E-9E3D-23278FE32871Q37663037-534CC661-4E07-424C-ADEB-564A47960F4CQ38703500-6091D77F-B1C8-42B2-9F29-8D7829F89F72Q38977316-A1F80069-B282-4349-A6C6-6555CE4A428BQ39044130-93746F04-97FA-42A6-B2BD-5EC8CFE4A977Q39044134-9FEAF03A-A2CD-48E5-BE4F-41132EC1AEA5Q39207106-E8BECEE2-B1E9-4B8D-8054-F59A3B825B48Q39884226-00DAE19D-C6A8-425C-BF12-B0904DAB55E4Q40100641-9322192E-C8C3-4B35-81BB-423CB4F676D6Q40386710-58EAB531-D2D8-4EB3-ACD6-50A852884F60Q40388087-EBEF9C3C-A4B8-4E51-98EA-05B5FA82E46DQ40388161-D7A14DDE-8100-494C-B534-AD089A945505Q40399049-910B7F80-984A-4807-A498-DB0406DDD71EQ40450843-5EBE5EC6-9E00-4A2E-8544-ED67BC245AF0Q40642421-05F20E0E-502A-41E8-B836-6F55ECCB054AQ41114857-C044FFD1-2EE5-4567-8336-855A0549CFD9Q41516189-82BAD294-411E-46A5-9D00-03E203B50AA6Q43128578-8BC57CEA-B252-4B22-A673-B6EC1946DE5DQ43264245-400FA416-4EA2-4DA1-A7D7-56E12DBB5F60Q43582076-EB81EE49-0DAA-4D82-9240-679CD671F637Q44035250-D090263B-D892-4F58-AFC2-D3BEB53F935FQ44036185-CCA4ADB1-DA16-440A-A201-5807159B5DECQ44177081-B7E28DE2-40F4-46AE-A5E0-C8CF4AFB5169Q44194020-1BCDF2A4-8475-4FEF-B52F-E38F14DB175BQ44452308-70D1F571-0EE3-4991-8D68-BAF6A713D415
P50
description
researcher ORCID ID = 0000-0003-3676-2018
@en
wetenschapper
@nl
name
Parissa Farnia
@ast
Parissa Farnia
@en
Parissa Farnia
@es
Parissa Farnia
@nl
type
label
Parissa Farnia
@ast
Parissa Farnia
@en
Parissa Farnia
@es
Parissa Farnia
@nl
prefLabel
Parissa Farnia
@ast
Parissa Farnia
@en
Parissa Farnia
@es
Parissa Farnia
@nl
P106
P1153
6603261582
P31
P496
0000-0003-3676-2018